# Mesalazine

## MezaVant XL 1200mg prolonged release

#### 一般可用

| 藥品代碼       | OMEZA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
|:---------------|:-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 適應症         | Treatment of moderately active ulcerative colitis                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| 用法用量       | 2.4 to 4.8g (2 to 4 tablets) QD                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| 肝功能異常     | 需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| 腎功能異常     | 需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| 禁忌           | U.S. labeling: Hypersensitivity to mesalamine， aminosalicylates， salicylates， or any component of the formulation (including suppository vehicle of vegetable fatty acid esters) Canadian labeling: Hypersensitivity to mesalamine， salicylates， or any component of the formulation; severe renal impairment (GFR <30 mL/minute/1.73 m2); severe hepatic impairment Additional contraindications per specific Canadian product labeling: Existing gastric or duodenal ulcer， urinary tract obstruction， use in children <2 years of age (Asacol， Asacol 800， Mesasal， Pentasa， Salofalk); hemorrhagic diathesis (Mesasal); patients unable to swallow intact tablet (Asacol， Asacol 800); renal parenchymal disease (Pentasa) |
| 副作用         | >10%: Central nervous system: Headache (2% to 35%)， pain (?14%) Gastrointestinal: Abdominal pain (1% to 18%)， eructation (16%)， nausea (3% to 13%) Respiratory: Pharyngitis (11%)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| 孕期用藥建議   | Compatible                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| 哺乳期用藥建議 | No (Limited) Human Data - Potential Toxicity 無(很少)資料 - 避免使用                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |

